Related references
Note: Only part of the references are listed.Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo
Leonard Moise et al.
CLINICAL IMMUNOLOGY (2012)
Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
Robert J. Kreitman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
Wenhai Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity
Wenhai Liu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
David J. FitzGerald et al.
CANCER RESEARCH (2011)
Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations
Faviel F. Gonzalez-Galarza et al.
NUCLEIC ACIDS RESEARCH (2011)
Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
Jason R. Cantor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen
Carla Oseroff et al.
JOURNAL OF IMMUNOLOGY (2010)
A Recombinant Immunotoxin Targeting CD22 With Low Immunogenicity, Low Nonspecific Toxicity, and High Antitumor Activity in Mice
Johanna K. Hansen et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Immunoproteomic Identification of Human T Cell Antigens of Mycobacterium tuberculosis That Differentiate Healthy Contacts from Tuberculosis Patients
Anbarasu Deenadayalan et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
THERAPY Immunogenicity of biologic therapies-we need tolerance
Charlotte L. M. Krieckaert et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics
Satoshi Nagata et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Aprotease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity
John E. Weldon et al.
BLOOD (2009)
Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
Robert J. Kreitman et al.
CLINICAL CANCER RESEARCH (2009)
Dealing with immunogenicity of biologicals: assessment and clinical relevance
Gerrit J. Wolbink et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Phase I study of SS1P a recombinant anti-mesothelin immunotoxin given as a bolus IV infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2007)
T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection
Naeem Khan et al.
JOURNAL OF IMMUNOLOGY (2007)
Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients
Masanori Onda et al.
JOURNAL OF IMMUNOLOGY (2006)
Scientific and regulatory considerations on the immunogenicity of biologics
Gopi Shankar et al.
TRENDS IN BIOTECHNOLOGY (2006)
A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy
FA Harding et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Monitoring of cellular responses after vaccination against tetanus toxoid:: Comparison of the measurement of IFN-γ production by ELISA, ELISPOT, flow cytometry and real-time PCR
J Tassignon et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Rationally engineered therapeutic proteins with reduced immunogenicity
S Tangri et al.
JOURNAL OF IMMUNOLOGY (2005)
The development of a modified human IFN-α2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection
TD Jones et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2004)
Foreignness as a matter of degree: the relative immunogenicity of peptide/MHC ligands
HA van den Berg et al.
JOURNAL OF THEORETICAL BIOLOGY (2004)
Elimination of an immunodominant CD4+ T cell epitope in human IFN-β does not result in an in vivo response directed at the subdominant epitope
VP Yeung et al.
JOURNAL OF IMMUNOLOGY (2004)
Vaccination in humans generates broad T cell cytokine responses
SC De Rosa et al.
JOURNAL OF IMMUNOLOGY (2004)
ProPred: prediction of HLA-DR binding sites
H Singh et al.
BIOINFORMATICS (2001)
Share Paper
